Janet M. Woodroof, M.D.

Professional Background

Medical degree from the University of Kansas Medical Center (KUMC). Anatomic and Clinical Pathology residency from KUMC Dept of Pathology. Hematopathology training module
at University of Nebraska Pathology department during residency.

• MD, Pathology, Univ. of Kansas-Medical Ctr.
• BS, Bachelor of Science, Medical Technology, University of Missouri at K.C.
• Residency, Anatomic & Clinical Pathology, University of Kansas Hospital
• Internship, Family Medicine, University of Kansas Medical School

• Kansas Medical License, Kansas State Board of Healing Arts
• Missouri Medical License, Missouri State Board of Registration for the Healing Arts

• Arthur Purty Stout Society of Surgical Pathologists, Member, 2016 - Present
• Association of Directors of Anatomic and Surgical Pathology, Member, 2015 - Present
• International Skeletal Society, Member, 2013 - Present
• International Society of Bone and Soft Tissue Pathology, Member, 2013 - Present
• American Society for Clinical Pathology, Fellow, 2005 - Present
• College of American Pathologists, Fellow, 2005 - Present
• United States and Canadian Academy of Pathology, Member, 2005 - Present

---

Research

Overview

Interests include hematopathology and head and neck pathology translational research, as well as quality assurance in pathology with focus on appropriate specimen handling and pathologist quality programs, with long term involvement in assessing and improving quality of bone marrow specimens.

• Kurundkar, A, Gao, X, Zhang, K, Britt, J., P, Siegal, G., P, Wei, S. 2018. Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases from a Single Institution. Clinical Breast Cancer (18), 30230-30231
• Mruthyunjayappa, S, Zhang, K, Zhang, L, Eltoum, I., A, Siegal, G., P, Wei, S. 2019. Synchronous and Metachronous Bilateral Breast Cancer: Clinicopathologic Characteristics and Prognostic Outcomes. Human Pathology (92), 1-9
• Wang, K, Hackney, J., R, Siegal, G., P, Wei, S. 2020. RANKLed by the Complexity of Signaling in Metastatic Breast Cancer to the Brain. Clinical Breast Cancer (30), 30071-30079
• Chen, R, Qarmali, M, Siegal, G., P, Wei, S. 2020. Receptor Conversion in Metastatic Breast Cancer: Analysis of 390 Cases from a Single Institution. Modern Pathology, 33 (12), 2499-2506
• Aldrees, R, Gao, X, Zhang, K, Siegal, G., P, Wei, S. 2021. Validation of the Revised 8th AJCC Breast Cancer Clinical Prognostic Staging System: Analysis of 5321 Cases from a Single Institution. Modern Pathology, 34 (2), 291-299
• Wei, S, Siegal, G., P. 2021. Small Round Cell Tumors of Soft Tissue and Bone. Archives of Pathology and Laboratory Medicine
• Fei, F, Siegal, G., P, Wei, S. 2021. Characterization of estrogen receptor-low-positive breast cancer. Breast Cancer Research and Treatment
• Memon, R, Prieto Granada, C., N, Harada, S, Winkour, T, Reddy, V, Kahn, A., G, Siegal, G., P, Wei, S. 2021. Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study. Clinical Breast Cancer (21), 132-134
• Fei, F, Siegal, G., P, Wei, S. 2021. Characterization of estrogen receptor-low-positive breast cancer. Breast Cancer Research and Treatment
• Wei, S. 2022. Update on selective special types of breast neoplasms: Focusing on controversies, differential diagnosis, and molecular genetic advances. Seminars in Diagnostic Pathology